Intellectual Property

ICSID Tribunal Dismisses Eli Lilly Patent Case Against Canada (March 16, 2017)

Author: 
Caitlin Behles

On March 16, 2017, an International Centre for Settlement of Investment Disputes (ICSID) Tribunal issued an

Court of Justice of the European Union Rules States May Not Impose General Obligations on Data Retention (December 21, 2016)

Author: 
Caitlin Behles

On December 21, 2016, the Court of Justice of the European Union

Court of Justice of the European Union Rules Beneficiary of Patent License Must Pay Royalty Even if it Does Not Infringe the Patented Technology (July 7, 2016)

Author: 
Catherina Valenzuela-Bock

On July 7, 2016, the Court of Justice of the European Union

SARS and International Law

The outbreak of a new infectious disease-Severe Acute Respiratory Syndrome (SARS)-in Asia and its spread to many countries in the Asian region and beyond raise many public health and policy questions and challenges for governments, international organizations, and non-governmental organizations. The SARS outbreak also implicates international law, and this Insight briefly discusses three areas of international law affected by SARS and the efforts to contain the spread of the disease.
 
Basic Information on the SARS Epidemic
 
Topic: 
Volume: 
8
Issue: 
7
Author: 
David P. Fidler
Image: 

Court of Justice of the European Union Upholds “Right to be Forgotten” in Google Case (May 13, 2014)

Author: 
Emily MacKenzie

On May 13, 2014, the Grand Chamber of the Court of Justice of the European Union (the Court)

Public Health and “Counterfeit” Medicines: The Role of the World Health Organization

Introduction

The normative and policy-setting functions of the World Health Organization (“WHO”) have been substantially influenced by the differences of opinion within WHO’s membership about the impact of trade and intellectual property (“IP”) rules on public health. In particular, WHO members differ as to the organization’s role in addressing the perceived failure of the pharmaceutical market to generate safe and affordable medicines for diseases predominantly affecting developing countries.

Topic: 
Volume: 
17
Issue: 
2
Author: 
Gian Luca Burci
PDF Version: 
Image: